Use access key #2 to skip to page content.
$23.43 -0.13 (-0.55%)
11/21/2008 12:55 PM

Merck & Co., Inc. (MRK)

CAPS Rating:
****

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.

View All Commentary (MRK)

Recs

0

Avatar cosmo2066 (57.27) Submitted: 6/06/07 11:40 AM : Outperform Start Price: $48.65 MRK Score: -2.04

Merck & Co., Inc. engages in the discovery, development, manufacture, and marketing of various products for human and animal health. MRK suffered from Vioxx litigation, but has largely recovered. This dividend machine is driven by a few key performers, acquisition of key technology, and strong research.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links